INTRODUCTION AND TAXONOMY

Complex Regional Pain Syndrome (CRPS) represents one of the most challenging and enigmatic neuropathic conditions encountered in orthopaedic surgery. Historically burdened by a confusing nomenclature—including reflex sympathetic dystrophy (RSD), causalgia, Sudeck’s atrophy, and Leriche posttraumatic syndrome—the condition was formally reclassified in 1994 by the International Association for the Study of Pain (IASP). This consensus taxonomy established the umbrella term CRPS to unify these clinical entities based on tissue damage and potential pain generation sites.

The taxonomy divides the syndrome into two distinct categories:
* CRPS Type I (formerly Reflex Sympathetic Dystrophy): Develops after an initiating noxious event (e.g., crush injury, fracture, tight cast) without an identifiable peripheral nerve injury.
* CRPS Type II (formerly Causalgia): Develops following a distinct, identifiable peripheral nerve injury. The clinical features of causalgia were first eloquently described by Mitchell, Morehouse, and Keen in 1867, following observations of median nerve injuries sustained by soldiers during the American Civil War.

Despite this taxonomic division, orthopaedic trauma frequently encompasses a combination of osseous, soft tissue, and neural injuries, leading to considerable clinical overlap. Regardless of the classification, CRPS is characterized by pain that is disproportionate in time or degree to the usual course of the inciting trauma, accompanied by a constellation of autonomic, sensory, and motor disturbances.

Clinical Pearl: Early recognition is the single most critical prognostic factor in CRPS. Diagnosis and intervention within the first 3 to 6 months yield a success rate of approximately 75%, whereas outcomes deteriorate precipitously if the diagnosis is delayed beyond one year.

PATHOPHYSIOLOGY AND NEUROBIOMECHANICS

The exact etiology of CRPS remains incompletely understood, but it is universally recognized as a multifactorial process involving aberrant inflammatory responses, vasomotor dysfunction, and maladaptive neuroplasticity. The pathophysiology can be divided into peripheral and central mechanisms.

Peripheral Sensitization and Neurogenic Inflammation

Following focal tissue trauma, an exaggerated peripheral inflammatory response occurs. Nociceptive C-fibers release neuropeptides, including Substance P and Calcitonin Gene-Related Peptide (CGRP). This neurogenic inflammation induces profound vasodilation, protein extravasation, and localized edema. Furthermore, an abnormal coupling between the sympathetic nervous system and sensory nerves develops. Upregulated alpha-1 adrenergic receptors on nociceptive fibers cause them to fire in response to circulating catecholamines, leading to sympathetically maintained pain (SMP).

Central Sensitization

Prolonged peripheral nociceptive input leads to central sensitization at the level of the spinal cord dorsal horn, brainstem, and somatosensory cortex. The continuous barrage of afferent signals activates N-methyl-D-aspartate (NMDA) receptors, resulting in the "wind-up" phenomenon—a state of hyperexcitability where normal tactile stimuli are perceived as painful (allodynia) and painful stimuli are exaggerated (hyperalgesia).

An imbalance in the homeostasis of ascending excitatory and descending inhibitory neural transmission patterns prevails. Neurotransmitters such as serotonin, norepinephrine, and endogenous opioids (endorphins, enkephalins) fail to adequately suppress the hyperactive pain pathways, resulting in a disproportionate pain response and eventual cortical reorganization. This cortical smudging often manifests clinically as motor neglect or the patient's psychological alienation of the involved limb.

CLINICAL PRESENTATION AND STAGING

The hallmark of CRPS is excruciating, burning pain, often described as throbbing, aching, or bursting pressure with a knifelike, stabbing component. The pain frequently extends beyond the cutaneous distribution of any single peripheral nerve and does not conform to standard dermatomes, myotomes, or sclerotomes.

Historically, CRPS has been described as progressing through three distinct clinical stages, though modern understanding recognizes that not all patients follow this linear progression.

Stage I: Acute (Hyperemic) Stage (0 to 3 Months)

Pain: Severe, burning, and disproportionate to the injury. Exacerbated by emotional stress, movement, or light touch.
Autonomic Changes: The extremity is typically warm, erythematous, and edematous due to vasodilation.
Sudomotor Changes: Hyperhidrosis (excessive sweating) is common.
Motor: Decreased range of motion secondary to pain and edema.

Stage II: Dystrophic (Ischemic) Stage (3 to 9 Months)

Vascular: The limb transitions from warm and red to cool, pale, cyanotic, or mottled.
Trophic Changes: Skin becomes thin, glossy, and dry. Hair growth may cease or become abnormal. Nails become brittle and heavily ridged.
Musculoskeletal: Increasing joint stiffness and early muscle atrophy. Radiographs may reveal the classic patchy periarticular osteopenia known as Sudeck’s atrophy.

Stage III: Atrophic Stage (> 9 Months)

Pain: May plateau or become highly variable, but remains intractable.
Trophic Changes: Profound atrophy of the skin, subcutaneous tissue, and intrinsic musculature.
Musculoskeletal: Irreversible joint contractures (e.g., claw hand). The limb is chronically cold and stiff.

Surgical Warning: Patients with CRPS may exhibit extreme protective behaviors. Some may wrap the limb in wet towels or refuse to look at it. This alienation is a result of cortical reorganization, not malingering, and requires validation and multidisciplinary psychiatric support.

DIAGNOSTIC EVALUATION

There is no single definitive laboratory test for CRPS; the diagnosis remains fundamentally clinical. The IASP Budapest Criteria are the current gold standard for diagnosis, requiring the presence of continuing pain disproportionate to the inciting event, along with specific sensory, vasomotor, sudomotor/edema, and motor/trophic signs and symptoms.

Objective Clinical Testing

Autonomic Testing: Interruption of a peripheral nerve or sympathetic dysregulation alters sweating. This can be mapped using the starch-iodine test, the Ninhydrin printing test (popularized by Aschan and Moberg), or the Richter dermometer for skin resistance.
Wrinkle Test (O’Riain and Leukens): Normal skin wrinkles when immersed in warm water for 30 minutes. Denervated or sympathetically abnormal skin fails to wrinkle, providing an objective measure of autonomic dysfunction.

Imaging Modalities

Triple-Phase Bone Scintigraphy (Technetium-99m): Highly sensitive (up to 96%) and specific (up to 98%) in the early stages of CRPS. The classic finding is diffusely increased periarticular tracer uptake in the delayed (third) phase.
Radiography: Plain films may demonstrate patchy, periarticular demineralization (Sudeck’s osteopenia), though this typically takes weeks to months to develop.
Magnetic Resonance Imaging (MRI): May show early soft tissue edema, muscle hyperpermeability, and skin thickening, though it is not consistently definitive.

ORTHOPAEDIC TRAUMA AND PERIPHERAL NERVE INJURIES

Orthopaedic surgeons must maintain a high index of suspicion for CRPS, particularly following specific fracture patterns associated with secondary neural injuries. Complete severance of a peripheral nerve abolishes all reflex activity, but partial injuries—where neither the afferent nor efferent arc is completely interrupted—are notorious for triggering CRPS II.

High-Risk Orthopaedic Injuries

Distal Radius Fractures: Carry one of the highest associations with CRPS I and II. Tight casting, extreme positioning (e.g., Cotton-Loder position), and iatrogenic median or superficial radial nerve injury are major culprits.
Humeral Shaft Fractures: Associated with radial nerve injuries in up to 14% of cases.
Elbow Trauma: Ulnar nerve injuries occur in about 30% of combined skeletal/neural upper extremity injuries, often secondary to medial epicondyle fractures or exuberant callus formation.
Shoulder Dislocations: Axillary nerve stretch injuries occur in approximately 5% of cases.
Lower Extremity Trauma: Peroneal nerve injuries at the fibular neck, and tibial nerve injuries following complex ankle fractures or pilon fractures, are well-documented triggers for lower extremity CRPS.

Pitfall: Failing to exclude a subtle peripheral nerve injury in an acute extremity fracture can lead to delayed diagnosis of CRPS II. Equal diligence must be applied postoperatively to detect secondary neural compression from hematoma, tight casts, or hardware.

SURGICAL AND INTERVENTIONAL MANAGEMENT

While CRPS is primarily managed non-operatively through a multidisciplinary approach, orthopaedic surgeons and pain specialists frequently employ interventional techniques to facilitate rehabilitation. When surgery is unavoidable in a patient with pre-existing CRPS, strict perioperative protocols must be followed to prevent disease exacerbation.

Preoperative Optimization for the CRPS Patient

Surgery on a limb with active or historical CRPS carries a high risk of triggering a severe flare.
* Prophylaxis: High-dose Vitamin C (500 mg daily for 50 days) has been shown to reduce the incidence of CRPS following distal radius fractures and should be considered for high-risk patients.
* Anesthesia: Regional anesthesia (axillary or supraclavicular blocks) is strongly preferred over general anesthesia to block afferent nociceptive input. Perioperative ketamine infusions (an NMDA receptor antagonist) are highly effective in mitigating central sensitization.

Sympathetic Blockade

For patients with sympathetically maintained pain, sympathetic blocks serve both diagnostic and therapeutic roles, providing a window of analgesia to allow for aggressive physical therapy.
* Upper Extremity (Stellate Ganglion Block): Performed under fluoroscopic or ultrasound guidance. The needle is advanced to the level of C6 (Chassaignac's tubercle) to avoid the vertebral artery and pleura. Local anesthetic is injected to block the cervical sympathetic chain. A successful block is confirmed by the onset of ipsilateral Horner's syndrome (ptosis, miosis, anhidrosis) and an increase in limb temperature.
* Lower Extremity (Lumbar Sympathetic Block): Performed fluoroscopically at the L2-L3 or L3-L4 level. The needle is advanced to the anterolateral border of the vertebral body, and anesthetic is deposited to bathe the lumbar sympathetic chain.

Neuromodulation: Spinal Cord Stimulation (SCS)

When conservative measures and sympathetic blocks fail, SCS is a highly effective, evidence-based intervention for chronic CRPS.
* Indications: Intractable CRPS > 6 months duration, failure of conservative therapy, and successful psychological clearance.
* Mechanism: Based on the Gate Control Theory of Pain, SCS delivers electrical impulses to the dorsal columns, activating inhibitory interneurons that suppress nociceptive transmission.
* Surgical Technique (Percutaneous Trial):
1. The patient is positioned prone on a radiolucent table.
2. Under fluoroscopic guidance, an epidural needle is advanced using a loss-of-resistance technique into the epidural space (typically lower thoracic for lower extremity, or upper thoracic/cervical for upper extremity).
3. The stimulation lead is advanced into the posterior epidural space and steered over the dorsal columns.
4. Intraoperative testing is performed to ensure the paresthesia coverage maps precisely over the patient's painful area.
5. If a 5-to-7-day trial provides >50% pain relief, a permanent implantable pulse generator (IPG) is surgically internalized.

Surgical Sympathectomy

Chemical or surgical sympathectomy is reserved for severe, refractory cases of sympathetically maintained CRPS that have responded transiently to temporary blocks.
* Upper Extremity: Endoscopic thoracic sympathectomy (ETS) involves excising the T2 and T3 ganglia. The T1 ganglion (lower third of the stellate ganglion) is strictly preserved to prevent permanent Horner's syndrome.
* Lower Extremity: Open or retroperitoneal endoscopic lumbar sympathectomy involves resection of the L2 and L3 ganglia.

Peripheral Nerve Decompression and Neurolysis

In cases of CRPS II (causalgia), where a distinct nerve entrapment or neuroma-in-continuity is identified, surgical intervention may be curative.
* Technique: Meticulous microsurgical neurolysis is performed to free the nerve from surrounding scar tissue, callus, or orthopaedic hardware. If a neuroma is present, it may require excision and nerve grafting, or targeted muscle reinnervation (TMR) to prevent recurrence.

POSTOPERATIVE PROTOCOLS AND REHABILITATION

The cornerstone of CRPS treatment is functional restoration. Interventions and medications are merely tools to facilitate movement.

Physical and Occupational Therapy

Stress Loading (Watson-Carlson Protocol): Involves active traction and compression exercises (e.g., scrubbing the floor with a brush, carrying a weighted briefcase). This provides proprioceptive input that helps normalize aberrant afferent signaling.
Mirror Visual Feedback Therapy: The patient places the affected limb behind a mirror and performs movements with the unaffected limb while watching its reflection. This creates a visual illusion of normal movement in the painful limb, helping to reverse cortical smudging and central sensitization.
Desensitization: Gradual exposure to varying textures (silk, cotton, Velcro) to reduce allodynia.

Pharmacologic Support

A multimodal analgesic approach is essential:
* Neuropathic Agents: Gabapentin or pregabalin to reduce ectopic nerve firing.
* Antidepressants: Tricyclic antidepressants (Amitriptyline) or SNRIs (Duloxetine) to enhance descending inhibitory pain pathways.
* Anti-inflammatories and Bisphosphonates: NSAIDs for acute inflammation, and bisphosphonates (e.g., Alendronate) which have shown efficacy in reducing pain and reversing osteoporotic changes in the dystrophic stage.

In conclusion, CRPS remains a formidable clinical entity requiring a high index of suspicion, rapid diagnosis, and an aggressive, multidisciplinary treatment paradigm. Orthopaedic surgeons must master the nuances of peripheral nerve anatomy, employ meticulous surgical technique to avoid iatrogenic injury, and utilize advanced interventional modalities to restore function and alleviate the profound suffering associated with this syndrome.

Creator: Dr. Mohammed hutaif
Published: 2026-04-12T14:30:55.327753+00:00

Authoritative Medical Review

This academic synthesis is based on established protocols from Hutaifortho's Operative Orthopaedics and has been medically reviewed by Prof. Dr. Mohammed Hutaif, Consultant Orthopedic & Spine Surgeon. It is designed to assist orthopedic residents, fellows, and practicing surgeons in surgical preparation and board reviews (AAOS, FRCS, Arab Board).

Clinical Disclaimer: The surgical techniques, indications, and medical guidance detailed herein are for advanced educational purposes only. They do not supersede institutional guidelines or independent surgical judgment.

Orthopedic Review | Dr Hutaif General Orthopedics Revie -...

Complex Regional Pain Syndrome in Orthopaedic Surgery: Pathophysiology, Diagnosis, and Interventional Management

Key Takeaway